New pathways in immune stimulation: targeting OX40-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

New pathways in immune stimulation: targeting OX40

Published:2020 Issue:1 Volume:5 Page:e000573
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

Alves Costa Silva Carolina^ORCID,Facchinetti Francesco,Routy Bertrand,Derosa Lisa

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference58 articles.

1. Adjuvant pembrolizumab versus placebo in resected stage III melanoma;Eggermont;N Engl J Med Overseas Ed,2018

2. Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma;Weber;N Engl J Med,2017

3. Durvalumab after chemoradiotherapy in stage III Non–Small-Cell lung cancer;N Engl J Med,2019

4. Loss of IFN-γ pathway genes in tumor cells as a mechanism of resistance to anti-CTLA-4 therapy;Gao;Cell,2016

5. Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations;Shin;Cancer Discov,2017

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between OX40L polymorphism and type 2 diabetes mellitus in Iranians;BMC Medical Genomics;2024-07-09

2. Impact of isotype on the mechanism of action of agonist anti-OX40 antibodies in cancer: implications for therapeutic combinations;Journal for ImmunoTherapy of Cancer;2024-07

3. The expression of immune co-stimulators as a prognostic predictor of head and neck squamous cell carcinomas and oral squamous cell carcinomas;Journal of Dental Sciences;2024-07

4. Many Faces of Regulatory T Cells: Heterogeneity or Plasticity?;Cells;2024-06-01

5. The involvement and application potential of exosomes in breast cancer immunotherapy;Frontiers in Immunology;2024-05-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3